| Technology Name | Briefcase | Lead Researcher |
|---|---|---|
Background
The process of cancer metastasis consists of a series of sequential events that requires deregulated proliferation and eventually distal dissemination involving detachment from the extracellular matrices and invasion of the ... More | Breuer Eli | |
Background
Micro-emulsions are formed more or less spontaneously when their components are brought into contact. They have been the only successful delivery systems for certain types of pharmaceutical compounds, particularly compounds such as ... More | Domb Abraham | |
Background
Peptides are key players in a variety of physiological and pathological processes and play very important roles in modulating various cell functions.
One of the most important challenges developing peptide drugs is the lack of ... More | Gilon Chaim | |
Background
Many of today’s leading compounds and drugs in pipeline fail to reach clinical stages due to poor oral bioavailability. In addition, Increase in oral bioavailability leads a lower inter and intra subject variability.
Our ... More | Domb Abraham | |
Background
As for today, an oral treatment to metastasis therapy is still an unmet challenge. We discovered a new approach to treat metastatic disease in that was verified in several preclinical models.
Our Innovation
A new approach to treat ... More | Reich Reuven |